Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...
A recent study of a million people with 14 psychiatric disorders showed these disorders fell into five genetic clusters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback